(R)-2-(Boc-aMino)-2-phenylethyl 4-Methylbenzenesulfonate CAS: 126610-77-3
| Product Parameters | |
|---|---|
| Catalog No. | BK6TX0 |
| CAS.RN | 126610-77-3 |
| Molecular Formula | C20H25NO5S |
| Molecular Weight | 391.48 g/mol |
| Purity | NLT 98% |
Product Overview
This product is a pharmaceutical intermediate, mainly used in the synthesis and preparation of anti-tumor drugs and novel targeted drugs. It is suitable for the entire process development cycle, including the research and development stage, small-scale trials, pilot-scale amplification and commercial production. It has good chemical stability and reactivity, and can be used as a key structural unit in multi-step synthetic routes. It is widely used in new drug research and development and process optimization.
Applications
- Antitumor drug synthesis
- Development of targeted drug intermediates
- Construction of peptide drugs
- Process route optimization research
- Customized synthesis of pharmaceutical raw materials
Quality & Supply Capability
English Name: (R)-2-(Boc-aMino)-2-phenylethyl 4-Methylbenzenesulfonate Properties: This product is an organic sulfonate compound containing a chiral center, exhibiting good thermal and chemical stability. Its core functional groups include a Boc protecting group, a phenylethyl structure, and a p-toluenesulfonate group, making it suitable for various coupling reactions and configuration-controlled synthesis. Storage Recommendations: Store in a sealed, light-protected, and dry place, subject to the COA/MSDS. Supply Capabilities: Samples, gram-level, kilogram-level, commercial batches. Packaging Specifications: Aluminum foil bags, fluorinated bottles, cardboard drums, customized packaging. Document Support: COA, MSDS, HPLC, NMR, etc. We provide sample supply, small-scale preparation, pilot-scale amplification, and customized batch production services. We can provide flexible supply solutions based on customer requirements for purity, impurity control, packaging specifications, delivery cycle, and quality documentation. We also provide technical support from laboratory R&D to scale-up production, helping customers advance process development, route optimization, and project transformation, ensuring efficient and compliant completion of the entire supply chain for pharmaceutical intermediates.
Why Choose Bioncan
Focused on pharmaceutical intermediates, possessing a rich product line and accumulated technology. Full-scale supply capabilities to meet diverse needs from laboratory to commercial production. Provides complete quality control documentation to ensure product quality and compliance. Supports customized needs, capable of synthesis and optimization according to specific customer requirements. Provides supporting process optimization technologies to help customers improve synthesis efficiency and yield.
Intermediates of Elagolix
| Catalog No. | Product Name | CAS |
|---|---|---|
| BA882A | Elagolix API | 834153-87-6 |
| BK6JT9 | Elagolix sodium | 832720-36-2 |
| BK6E31 | 5-(2-fluoro-3-methoxyphenyl)-1-(2-fluoro-6-(trifluoromethyl)benzyl)-6-methylpyrimidine-2,4(1H,3H)-dione | 1150560-59-0 |
| BK703Q | 5-Bromo-1-(2-fluoro-6-trifluoromethyl-benzyl)-6-methyl-1H-pyrimidine-2,4-dione | 830346-48-0 |
| BK89X0 | 1-(2-Fluoro-6-trifluoromethyl-benzyl)-6-methyl-1H-pyrimidine-2,4-dione | 830346-47-9 |
| BK98G8 | 2-Fluoro-3-methoxyphenylboronic acid | 352303-67-4 |
| BK6Q07 | 1-(2-fluoro-6-(trifluoromethyl)benzyl)urea | 830346-46-8 |
| BK852Z | 2-Fluoro-6-(trifluoromethyl)benzylamine | 239087-06-0 |
| BK28G0 | 1-(2-Fluoro-6-(trifluoromethyl)benzyl)-5-iodo-6-methylpyrimidine-2,4(1h,3h)-dione | 1150560-54-5 |
| BK6TX0 | (R)-2-(Boc-aMino)-2-phenylethyl 4-Methylbenzenesulfonate | 126610-77-3 |
Customers are responsible for ensuring compliance with applicable patent, regulatory, and import/export requirements in their respective jurisdictions.
Online Consulting
For quotation, inventory, samples, COA, MSDS, or custom synthesis support for CAS 126610-77-3, please submit your requirements. We will respond according to purity, quantity, delivery timeline, and documentation needs.